Correlation Between Ardelyx and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Allogene Therapeutics, you can compare the effects of market volatilities on Ardelyx and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Allogene Therapeutics.
Diversification Opportunities for Ardelyx and Allogene Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ardelyx and Allogene is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Ardelyx i.e., Ardelyx and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Ardelyx and Allogene Therapeutics
Given the investment horizon of 90 days Ardelyx is expected to under-perform the Allogene Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ardelyx is 1.09 times less risky than Allogene Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Allogene Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 250.00 in Allogene Therapeutics on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Allogene Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ardelyx vs. Allogene Therapeutics
Performance |
| Timeline |
| Ardelyx |
| Allogene Therapeutics |
Ardelyx and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Allogene Therapeutics
The main advantage of trading using opposite Ardelyx and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.The idea behind Ardelyx and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |